Meet The Team
Our Vision
To position South Africa as a global leader in the 21st century bioeconomy – driven by innovation, infrastructure, and scientific excellence.
Our Mission
To deliver OMICS-driven solutions that close innovation gaps, unlock opportunities, and accelerate the growth of South Africa’s modern biotechnology sector
How We Work
We operate at the intersection of science, technology, and precision We deliver tailored OMICS solutions under rigorous quality management systems, ensuring reliability across research, regulatory, and commercial applications. With cutting-edge, integrated technologies, we drive results that meet the highest standards—every time.
From Concept to Discovery: Our Three-Step Approach
We turn your scientific vision into actionable outcomes through a streamlined, high-impact process:

1. Plan
- We begin with a focused consultation to understand your research goals, technical needs, and desired outcomes. Together, we define the project scope – including the type and scale of OMICS analyses and ensuring alignment with your objectives and timelines.

2. Execute
- We deploy cutting-edge OMICS and multi-OMICS technologies to generate high-quality, insight-rich data.
- Targeted OMICS: Generate meaningful insights and identify biomarkers or molecular drivers.
- Integrated Multi-OMICS: Deliver comprehensive views across systems biology.
- Quality Control: Apply rigorous validation protocols to ensure data accuracy and integrity.

3. Translate
- We transform complex data into clear answers.
- Use robust tools and algorithms to extract relevant biological meaning.
- Tailored Analysis: Adapt pipelines to your specific research questions.
- Deliver results in clear, concise reports with intuitive data visualizations to support decision-making and communication.
Our Legacy
Centre for Proteomic and Genomic Research (CPGR) stands at the forefront of South Africa’s drive as a global leader in the 21st-century bioeconomy. As a catalyst for OMICS innovation (spanning Genomics, Proteomics, and Bioinformatics) we deliver high-impact, integrated solutions that advance life science research and commercial biotechnology development.
Founded in 2006 through a strategic initiative by South Africa’s Department of Science, Technology and Innovation (DSTI), and supported by the Technology Innovation Agency (TIA), CPGR was established to provide researchers and industry partners with access to advanced, capital-intensive technologies—enabling breakthroughs in publication, patenting, and product development.
All services are delivered through a robust ISO 9001:2015-certified quality management system, ensuring consistency, compliance, and scientific excellence.
CPGR has catalyzed the creation of leading biotech ventures, including Mediclinic Precise (formerly Artisan Biomed, est. 2015) and D-CYPHR (est. 2022), and currently hosts DIPLOMICS, a national OMICS infrastructure program funded by the DSI.
With over 1200 OMICS projects successfully executed, we continue to lead with the latest technologies, turning scientific ambition into measurable outcomes and contributing to a thriving biotechnology ecosystem in South Africa and beyond.
We kick off with a bold vision—developing our first business plan under a national initiative led by the Department of Science and Technology (DSTI), with funding support from the Technology Innovation Agency (TIA).
By December, we secure additional investment from the Cape Biotech Trust, setting the stage for what’s to come.
We officially establish ourselves as a non-profit company in April 2006, operating under Section 21 and based in Cape Town.
By September, we set up our first laboratory at the University of Cape Town (UCT), laying the groundwork for our future in OMICS innovation.
We go fully operational in early 2007, launching our capabilities and stepping confidently into the OMICS research landscape.
We expand our footprint, opening a new office at St Peter’s Square Mall in Observatory, Cape Town — a key step in scaling our operations and impact.
We launch our first Genomics laboratory at St Peter’s Square Mall, Observatory, strengthening our technical capabilities and expanding our research capacity.
(NGS) Laboratory
We establish our Next Generation Sequencing (NGS) laboratory at St Peter’s Square Mall, taking a major leap forward in high-throughput genomic research.
DIPLOMICS Launch
In August, we earn ISO 9001:2008 certification, reinforcing our commitment to quality and operational excellence.
From September, we host, govern, and manage DIPLOMICS—a national, distributed OMICS platform established through the DSTI’s SARIR program—strengthening South Africa’s research infrastructure.
We launch Artisan Biomed to deliver precision medicine in the South African healthcare sector, combining advanced molecular testing with clinical insight through a key partnership with Lancet Laboratories.
Launch
We establish our new facility at 108 Albert Road in Woodstock, Cape Town—expanding infrastructure.
We launch D-CYPHR, an advanced proteomics and metabolomics program supported by DIPLOMICS, DSTI, and TIA.
Projects